LONDON, Oct. 15, 2026 (GLOBE NEWSWIRE) -- DaltonTx, the decision engine for drug discovery, today announces that it has been awarded a grant by the Gates Foundation to advance tuberculosis (TB) drug discovery programmes using its AI-enabled platform, Dalton. The award marks a…
Founded by leaders from OpenAI, Terremoto Biosciences, Meta, Devoted Health, and the White House, Warp is using AI and robotics to help biotech and pharma discover new medicines faster in the U.S. The company is backed by Lightspeed, IVP, Mayfield, Lux,…
AI drug discovery is often described with the image of AI coming up with new drug candidates, but its scope of application goes beyond just molecular design. However, 'companies have partnered,' 'a promising candidate has been found,' and 'efficacy has…
Etcelera unites the platform technologies of Cellarity, Etiome, and Empress Therapeutics with Flagship Pioneering's proprietary AI capabilities to scale causal intelligence in human biology Veteran... Etcelera unites the platform technologies of Cellarity, Etiome, and Empress Therapeutics with Flagship Pioneering's proprietary…
Anthropic is expanding into biotechnology through drug-development partnerships, its own biology laboratory, and the acquisition of a company researching rare muscular diseases, bringing the artificial intelligence company deeper into the search for new medicines. In a new announcement, Anthropic outlined…
Anthropic critics are watching its IPO and worrying that revenue growth is slowing. They may be measuring the wrong thing. This week, the company revealed that it acquired a one-person biotech that used Claude to coordinate 11 outside laboratories and advance…
AI drug discovery has spent years promising faster ways to find medicines. Rentosertib is now raising a more unexpected possibility. Insilico Medicine said patients who received the AI-assisted experimental drug in an earlier pulmonary-fibrosis trial showed changes in biological-age measurements…
Claude is moving beyond the chat window and into drug discovery, helping researchers search for a potential food-allergy treatment. In roughly a month, the AI generated about 35,000 antibody designs, and early laboratory tests identified several promising candidates. Anthropic disclosed the…
EPFL scientists introduce ChemCrow, a large language model-based AI system that revolutionizes chemistry by integrating 18 advanced tools for tasks like organic synthesis and drug discovery. ChemCrow streamlines complex processes in chemical research, making it more efficient for experts and novices…
A machine learning pipeline trained on 192 FDA-approved compounds predicts human oral bioavailability with an R2 of 0.766, outperforming previous models and single-species animal correlations. Subject of Research: Machine learning prediction of human oral drug bioavailability from preclinical animal and molecular data Article…
Artificial intelligence used to find and design medicines: AI drug-discovery companies, generative chemistry and AI-discovered drugs in trials.
An article joins this feed when it matches these terms. Each one is also a search of its own.